Updated 09/09/2010 08:29 AM
Health Beat: Zapping overactive bladders
By: Ivanhoe Broadcast News
To view our videos, you need to
enable JavaScript. Learn how.
install Adobe Flash 9 or above. Install now.
Then come back here and refresh the page.
Contrary to popular belief, both women and men suffer from overactive bladders equally. Symptoms in men often are mistaken for other problems, like an enlarged prostate.
In the United States, about 33 million people suffer from overactive bladder and other forms of urinary incontinence. Signs and symptoms of an overactive bladder include feeling a sudden and strong urge to urinate, experiencing the involuntary loss of urine immediately following an urgent need to urinate and urinating frequently.
Chris Gale, Vice President
EVC Group, Inc.
(646) 201-5431
cgale@evcgroup.com
According to a study in the Journal of Urology, fewer than half of women and less than one-quarter of men who experience these symptoms ever talk to their doctor about the problem. Experts say it is also important to talk to your doctor because an overactive bladder may occur as a result of a serious underlying problem, such as a cancerous tumor.
Behavioral interventions can help manage an overactive bladder. You can limit the amount of caffeinated and alcoholic beverages you consume because they may worsen the symptoms.
Eating a diet rich in fiber or taking fiber supplements may also help. Doctors often recommend a strategy to train patients to delay the urge to urinate. There are also many medications on the market that relax the bladder and can help alleviate symptoms. These drugs include tolterodine (Detrol), oxybutynin (Ditropan) and solifenacin (Vesicare). However, these drugs do have common side effects including dry eyes, dry mouth and constipation.
Percutaneous tibial nerve stimulation is a new neuromodulation therapy that has proven to be an effective treatment for patients with an overactive bladder. It uses electrical stimulation to target specific nerves in the sacral plexus that controls bladder function. The treatment targets the sacral plexus from an accessible and minimally-invasive entry point in the nervous system.
"We usually see that patients don't necessarily benefit immediately after a therapy session. Our experience is that it takes about four sessions before they really start to appreciate significant improvement in their symptoms," Suzette E. Sutherland, M.D., said.
In one study, about 55 percent of patients reported significant improvement with PTNS. However, it is not always covered by insurance. Each session can cost between $200 and $250.